Stem Cells Derived from Tooth Periodontal Ligament Enhance Functional Angiogenesis by Endothelial Cells

• Published in: Tissue engineering. Part A 2014-04, Vol.20 (7-8), p.1188-1196
• Main Authors: Yeasmin, Shamima, Ceccarelli, Jacob, Vigen, Marina, Carrion, Bita, Putnam, Andrew J., Tarle, Susan A., Kaigler, Darnell
• Format: Article
• Language: English
• Subjects: Angiogenesis; Animals; Blood Vessels - growth & development; Capillary Permeability; Cytokines - biosynthesis; Endothelial Cells - cytology; Humans; Ligaments; Mice, SCID; Multipotent Stem Cells - cytology; Neovascularization, Physiologic; Original; Original Articles; Periodontal Ligament - cytology; Stem cells; Stem Cells - cytology; Teeth; Tissue engineering; Tooth - cytology
• ISSN: 1937-3341; 1937-335X
• DOI: 10.1089/ten.tea.2013.0512

In regenerative medicine approaches involving cell therapy, selection of the appropriate cell type is important in that the cells must directly (differentiation) or indirectly (trophic effects) participate in the regenerative response. Regardless of the mode of action of the cells, angiogenesis underlies the success of these approaches. Stem cells derived from tooth tissues, specifically the periodontal ligament of teeth (periodontal ligament stem cells [PDLSCs]), have recently been identified as a good source of multipotent cells for cell therapies. PDLSCs have demonstrated properties similar to mesenchymal stem cells (MSCs), yet, unlike MSCs, their vascular potential has not been previously demonstrated. Thus, the aim of this study was to determine if PDLSCs could modulate angiogenesis. In comparison to MSCs and stem cells derived from tooth pulp tissues (SHEDs), we first determined if PDLSCs released soluble proangiogenic factors with the capacity to induce vessel formation by endothelial cells (ECs). Next, the ability of PDLSCs to modulate angiogenesis was examined through their cotransplantation with ECs in subcutaneous sites of immunocompromised mice. Finally, the stability of the PDLSC-mediated vasculature was determined through evaluation of the maturity and functionality of the vessels formed following PDLSC transplantation. It was determined that PDLSCs produced appreciable levels of vascular endothelial growth factor and basic fibroblast growth factor-2, and additionally, were able to initiate in vitro angiogenesis of ECs comparable to MSC- and SHED-mediated angiogenesis. In vivo cotransplantation of ECs with PDLSCs significantly (>50% increase) enhanced the number of blood vessels formed relative to transplantation of ECs alone. Finally, vessels formed following PDLSC cotransplantation were more mature and less permeable than those formed after transplantation of EC alone. These data demonstrate for the first time that PDLSCs have vascular potential, which could make them a very attractive cell population for utilization in regenerative cell therapies.